" /> Drug Development Process - CISMeF





Preferred Label : Drug Development Process;

NCIt definition : The process by which an investigational product is brought to the market through a series of preclinical and clinical testing, regulatory review, and approval.;

Alternative definition : CDISC-GLOSS: The program for advancing an investigational product from preclinical studies through approval for marketing following review by regulatory agencies.;

NCI Metathesaurus CUI : CL540512;

Détails


Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.